Abstract
There is compelling evidence that statin therapy improves cardiovascular morbidity and mortality. Unfortunately, statin adherence is far from optimal regarding initiation, execution and persistence of treatment over time.26 Poor adherence to statin therapy is associated with a significantly increased risk of cardiovascular events and mortality. Evidence-based steps to improve adherence are available and should be taken in order to improve patient outcomes. Reinforcing statin adherence appears to have at least as strong beneficial effects as introducing a new drug.
Original language | English |
---|---|
Pages (from-to) | 2473-2477b |
Number of pages | 7 |
Journal | European Heart Journal |
Volume | 38 |
Issue number | 32 |
DOIs | |
Publication status | Published - 21 Aug 2017 |
Keywords
- DENSITY-LIPOPROTEIN CHOLESTEROL
- C-REACTIVE PROTEIN
- CARDIOVASCULAR-DISEASE
- PRIMARY NONADHERENCE
- CLINICAL-PRACTICE
- MYOCARDIAL-INFARCTION
- LOWERING MEDICATIONS
- SECONDARY PREVENTION
- PATIENT EDUCATION
- DRUG-THERAPY